Thrivent Financial for Lutherans’s Ascendis Pharma ASND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-35,941
| Closed | -$4.95M | – | 2363 |
|
|
2024
Q4 | $4.95M | Sell |
35,941
-42,532
| -54% | -$5.86M | 0.01% | 914 |
|
|
2024
Q3 | $11.7M | Buy |
78,473
+228
| +0.3% | +$34K | 0.02% | 628 |
|
|
2024
Q2 | $10.7M | Sell |
78,245
-36,156
| -32% | -$4.93M | 0.02% | 642 |
|
|
2024
Q1 | $17.3M | Buy |
114,401
+1,137
| +1% | +$172K | 0.03% | 502 |
|
|
2023
Q4 | $14.3M | Sell |
113,264
-2,190
| -2% | -$276K | 0.03% | 523 |
|
|
2023
Q3 | $10.8M | Buy |
115,454
+1,502
| +1% | +$141K | 0.03% | 580 |
|
|
2023
Q2 | $10.2M | Sell |
113,952
-13,164
| -10% | -$1.17M | 0.02% | 641 |
|
|
2023
Q1 | $13.6M | Buy |
127,116
+1,918
| +2% | +$206K | 0.03% | 524 |
|
|
2022
Q4 | $15.3M | Buy |
125,198
+2,270
| +2% | +$277K | 0.04% | 480 |
|
|
2022
Q3 | $12.7M | Sell |
122,928
-13,051
| -10% | -$1.35M | 0.03% | 518 |
|
|
2022
Q2 | $12.6M | Sell |
135,979
-10,252
| -7% | -$953K | 0.03% | 531 |
|
|
2022
Q1 | $17.2M | Sell |
146,231
-3,326
| -2% | -$390K | 0.03% | 516 |
|
|
2021
Q4 | $20.1M | Sell |
149,557
-4,802
| -3% | -$646K | 0.04% | 467 |
|
|
2021
Q3 | $24.6M | Sell |
154,359
-25,244
| -14% | -$4.02M | 0.05% | 401 |
|
|
2021
Q2 | $23.6M | Buy |
179,603
+13,642
| +8% | +$1.79M | 0.05% | 409 |
|
|
2021
Q1 | $21.4M | Buy |
+165,961
| New | +$21.4M | 0.05% | 426 |
|